COMMUNIQUÉS West-GlobeNewswire

Novo and Hengrui Pharma enter exclusive license agreement for once-weekly oral GLP-1/GIP dual receptor agonist HRS-1596
29/09/2026
HRS-1596 is a phase 1-ready GLP-1/GIP dual receptor agonist for once-weekly oral dosing Total potential deal value is up to 2.6 billion US dollars, including 300 million dollars upfront, as well as potential sales [...]
IBA signe un contrat pour installer le premier centre de protonthérapie du centre de l'Italie, à Rome
29/09/2026
Louvain-la-Neuve, Belgique, le 29 septembre 2026, 7h00 - IBA (Ion Beam Applications S.A., EURONEXT), leader mondial des technologies d’accélération de particules et principal fournisseur de solutions de protonthérapie [...]
IBA signs contract to install the first proton therapy center in central Italy, in Rome
29/09/2026
Louvain-La-Neuve, Belgium, September 29, 2026 at 7 a.m. CEST – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions [...]
Pharming announces CEO transition
29/09/2026
Leiden, the Netherlands, September 29, 2026 : Pharming (Euronext Amsterdam: PHARM/Nasdaq: PHAR), a global biotechnology company focused on rare immune and genetic diseases, today announced that the Board of Directors [...]
Carbios et le Consortium «fiber-to-fiber» valident la production industrielle de t-shirts en polyester recyclé fabriqués à partir de déchets plastiques et textiles complexes.
29/09/2026
Production de t-shirts en polyester recyclé de haute performance grâce à la technologie de Carbios Une validation complète sur l’ensemble de la chaîne de valeur textile, du recyclage préindustriel à la transformation [...]
Carbios and the Fiber-to-Fiber Consortium successfully validate the industrial-scale production of recycled polyester T-shirts made from complex plastic and textile waste.
29/09/2026
Production of high-performance recycled polyester T-shirts enabled by Carbios’ technology Full validation across the textile value chain, from pre-industrial recycling to industrial-scale manufacturing Identical [...]
AB Science fait le point sur son plan de developpement et son calendrier financier à la suite d'une inspection promoteur des bonnes pratiques cliniques
29/09/2026
COMMUNIQUE DE PRESSE AB SCIENCE FAIT LE POINT SUR SON PLAN DE DEVELOPPEMENT ET SON CALENDRIER FINANCIER À LA SUITE D'UNE INSPECTION PROMOTEUR DES BONNES PRATIQUES CLINIQUES Confirmation de la pertinance d’avoir, parmi [...]
AB Science provides an update on its development plan and financial calendar following a sponsor Good Clinical Practice inspection
29/09/2026
PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON ITS DEVELOPMENT PLAN AND FINANCIAL CALENDAR FOLLOWING A SPONSOR GOOD CLINICAL PRACTICE INSPECTION Confirmation of the relevance of having, among the first decisions of the [...]
Quantum-Si Presents Interim Proteus™ Data at World HUPO 2026 Demonstrating a Significant Step Change in Performance Compared to Platinum® Pro
29/09/2026
All measurable sequencing metrics show profound improvement over Platinum Pro BRANFORD, Conn., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a [...]
Evosep and Mass Dynamics Join Forces to Standardize Proteomics Sample Preparation for Pharma
29/09/2026
SINGAPORE, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Evosep™, a global leader in standardized proteomics workflows, today announced a strategic collaboration with Mass Dynamics™, the collaborative software environment for [...]
NewGen Announces Pricing of $1.25 Million Public Offering
29/09/2026
BANGKOK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (the “Company”), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative [...]
Rancho Bernardo Dentistry Releases Patient Guide Comparing Professional Teeth Whitening and At-Home Kits
28/09/2026
Rancho Bernardo dentist Dr. James Spalenka says, “The biggest whitening mistake patients make is choosing convenience over supervision, and it's costing them results” San Diego, CA 92128, Sept. 28, 2026 (GLOBE NEWSWIRE [...]
Olivaro Drops Publishes 2026 Supplement Facts and Serving Information for Its Liquid Dietary Supplement
28/09/2026
Chromium Picolinate, Maca, Gymnema, and a 200 mg Proprietary Blend: Olivaro's Full Ingredient List and Serving Directions Explained Lakeland, FL, Sept. 28, 2026 (GLOBE NEWSWIRE) -- These statements have not been [...]
Egetis Therapeutics Announces U.S. FDA Approval of EMCITATE® (tiratricol) for Patients with MCT8 Deficiency
28/09/2026
First and only FDA-approved treatment of peripheral thyrotoxicosis in adults and pediatric patients with monocarboxylate transporter 8 (MCT8) deficiency in the United States Egetis launches Egetis RareLink™, the [...]
Currus Biologics announces FDA IND clearance for Phase 1 trial of CUR-001 in mesothelin-positive advanced refractory solid tumours
29/09/2026
The first clinical programme from Currus’ BEAT platform, designed to overcome the barriers that have limited CAR T-cell therapy in solid tumours CUR-001 combines CURB-001, Currus’ BEAT bispecific antibody, with CURT-001 [...]
Mint Ops becomes an official reseller of the Coro cybersecurity platform, bringing single-platform security to Canadian dental practices
29/09/2026
The dental business services company secured its own infrastructure with Coro before offering it to clients - and is publishing its pricing, per user, on day one. Winnipeg, MANITOBA, Sept. 28, 2026 (GLOBE NEWSWIRE) -- [...]
HUTCHMED Announces Submission of US NDA for ORPATHYS® plus TAGRISSO® in MET-Driven EGFR-Mutated Lung Cancer
29/09/2026
— Filing seeks approval for a biomarker-directed, all-oral treatment option for patients whose tumors have MET overexpression or amplification, after progression on an EGFR-TKI therapy — — Application supported by [...]
Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences
29/09/2026
SAN DIEGO, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Belite Bio , Inc (NASDAQ: BLTE) (“Belite Bio ® ” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative [...]
ProText Mobility Issues Significant Inter-Quarter Shareholder Update: ABSA Confirms Inaugural Digital-Asset Custody Pilot as TXTM Advances Global RWA and Uplist Strategy
28/09/2026
Company highlights a significant institutional milestone, advancing its intended regulated-exchange uplist through institutional custody, deployed SVLT infrastructure, proprietary nanotechnology, international real- [...]

Pages